{"id":"https://openalex.org/W2990931063","doi":"https://doi.org/10.31083/ph.2019.9626","title":"Safety, pharmacokinetics and efficacy of donafenib in treating advanced hepatocellular carcinoma: report from a phase 1b trial","display_name":"Safety, pharmacokinetics and efficacy of donafenib in treating advanced hepatocellular carcinoma: report from a phase 1b trial","publication_year":2019,"publication_date":"2019-11-01","ids":{"openalex":"https://openalex.org/W2990931063","doi":"https://doi.org/10.31083/ph.2019.9626","mag":"2990931063","pmid":"https://pubmed.ncbi.nlm.nih.gov/31739839"},"language":"en","primary_location":{"id":"doi:10.31083/ph.2019.9626","doi":"https://doi.org/10.31083/ph.2019.9626","is_oa":true,"landing_page_url":"https://doi.org/10.31083/ph.2019.9626","pdf_url":"https://storage.imrpress.com/IMR/hmed/application/10.1691/ph.2019.9626.pdf","source":{"id":"https://openalex.org/S175310056","display_name":"Die Pharmazie","issn_l":"0031-7144","issn":["0031-7144","3053-691X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320695","host_organization_name":"Avoxa","host_organization_lineage":["https://openalex.org/P4310320695"],"host_organization_lineage_names":["Avoxa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://storage.imrpress.com/IMR/hmed/application/10.1691/ph.2019.9626.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061463319","display_name":"Jingrui Liu","orcid":"https://orcid.org/0009-0007-3162-7307","observed_orcids":["https://orcid.org/0009-0007-3162-7307"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jingrui Liu","raw_affiliation_strings":["Phase I Clinical Trial Unit , The First Hospital of Jilin University , No. 71 Xinmin Street , Changchun , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase I Clinical Trial Unit , The First Hospital of Jilin University , No. 71 Xinmin Street , Changchun , China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101923362","display_name":"Xiaojiao Li","orcid":"https://orcid.org/0000-0002-2936-7864","observed_orcids":["https://orcid.org/0000-0002-2936-7864"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaojiao Li","raw_affiliation_strings":["Phase I Clinical Trial Unit , The First Hospital of Jilin University , No. 71 Xinmin Street , Changchun , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase I Clinical Trial Unit , The First Hospital of Jilin University , No. 71 Xinmin Street , Changchun , China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100430322","display_name":"Hong Zhang","orcid":"https://orcid.org/0000-0002-8546-8555","observed_orcids":["https://orcid.org/0000-0002-8546-8555"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hong Zhang","raw_affiliation_strings":["Phase I Clinical Trial Unit , The First Hospital of Jilin University , No. 71 Xinmin Street , Changchun , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase I Clinical Trial Unit , The First Hospital of Jilin University , No. 71 Xinmin Street , Changchun , China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102815186","display_name":"Guiling Chen","orcid":"https://orcid.org/0009-0004-7343-6996","observed_orcids":["https://orcid.org/0009-0004-7343-6996"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Guiling Chen","raw_affiliation_strings":["Phase I Clinical Trial Unit , The First Hospital of Jilin University , No. 71 Xinmin Street , Changchun , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase I Clinical Trial Unit , The First Hospital of Jilin University , No. 71 Xinmin Street , Changchun , China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100420422","display_name":"Hong Chen","orcid":"https://orcid.org/0000-0002-1867-1107","observed_orcids":["https://orcid.org/0000-0002-1867-1107"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hong Chen","raw_affiliation_strings":["Phase I Clinical Trial Unit , The First Hospital of Jilin University , No. 71 Xinmin Street , Changchun , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase I Clinical Trial Unit , The First Hospital of Jilin University , No. 71 Xinmin Street , Changchun , China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100755017","display_name":"Yue Hu","orcid":"https://orcid.org/0000-0001-8226-666X","observed_orcids":["https://orcid.org/0000-0001-8226-666X"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yue Hu","raw_affiliation_strings":["Phase I Clinical Trial Unit , The First Hospital of Jilin University , No. 71 Xinmin Street , Changchun , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase I Clinical Trial Unit , The First Hospital of Jilin University , No. 71 Xinmin Street , Changchun , China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011767765","display_name":"Junqi Niu","orcid":"https://orcid.org/0000-0001-5415-2024","observed_orcids":["https://orcid.org/0000-0001-5415-2024","https://orcid.org/0000-0002-9857-6520"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Junqi Niu","raw_affiliation_strings":["Department of Hepatology 2 , The First Hospital of Jilin University , Jilin , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatology 2 , The First Hospital of Jilin University , Jilin , China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101947274","display_name":"Yanhua Ding","orcid":"https://orcid.org/0000-0001-5342-370X","observed_orcids":["https://orcid.org/0000-0001-5342-370X"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yanhua Ding","raw_affiliation_strings":["Department of Hepatology 2 , The First Hospital of Jilin University , Jilin , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatology 2 , The First Hospital of Jilin University , Jilin , China","institution_ids":["https://openalex.org/I4210125137"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210125137"],"apc_list":null,"apc_paid":null,"fwci":2.2508,"has_fulltext":true,"cited_by_count":27,"citation_normalized_percentile":{"value":0.88112031,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"74","issue":"11","first_page":"688","last_page":"693"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/donafenib","display_name":"donafenib","score":1.0},{"id":"https://openalex.org/keywords/advanced-hepatocellular-carcinoma","display_name":"advanced hepatocellular carcinoma","score":0.8889999985694885},{"id":"https://openalex.org/keywords/multikinase-inhibitor","display_name":"multikinase inhibitor","score":0.9819999933242798},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8489999771118164},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7960000038146973},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8069999814033508},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.597000002861023},{"id":"https://openalex.org/keywords/transaminase-elevation","display_name":"transaminase elevation","score":0.746999979019165},{"id":"https://openalex.org/keywords/hypocalcemia","display_name":"hypocalcemia","score":0.968999981880188},{"id":"https://openalex.org/keywords/skin-toxicity","display_name":"skin toxicity","score":0.9559999704360962},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.7820000052452087},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.4699999988079071}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.908726692199707},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8804406523704529},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.848074197769165},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8170883655548096},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7544980049133301},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6102169156074524},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5548504590988159},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5103597044944763},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4574872553348541},{"id":"https://openalex.org/C2776877979","wikidata":"https://www.wikidata.org/wiki/Q424288","display_name":"Transaminase","level":3,"score":0.44432199001312256},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4214043915271759},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.41340476274490356},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3848363161087036},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044466","descriptor_name":"Asian People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.31083/ph.2019.9626","doi":"https://doi.org/10.31083/ph.2019.9626","is_oa":true,"landing_page_url":"https://doi.org/10.31083/ph.2019.9626","pdf_url":"https://storage.imrpress.com/IMR/hmed/application/10.1691/ph.2019.9626.pdf","source":{"id":"https://openalex.org/S175310056","display_name":"Die Pharmazie","issn_l":"0031-7144","issn":["0031-7144","3053-691X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320695","host_organization_name":"Avoxa","host_organization_lineage":["https://openalex.org/P4310320695"],"host_organization_lineage_names":["Avoxa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"journal-article"},{"id":"pmid:31739839","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31739839","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"Clinical Trial, Phase I"},{"id":"mag:2990931063","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31739839","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"doi:10.31083/ph.2019.9626","doi":"https://doi.org/10.31083/ph.2019.9626","is_oa":true,"landing_page_url":"https://doi.org/10.31083/ph.2019.9626","pdf_url":"https://storage.imrpress.com/IMR/hmed/application/10.1691/ph.2019.9626.pdf","source":{"id":"https://openalex.org/S175310056","display_name":"Die Pharmazie","issn_l":"0031-7144","issn":["0031-7144","3053-691X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320695","host_organization_name":"Avoxa","host_organization_lineage":["https://openalex.org/P4310320695"],"host_organization_lineage_names":["Avoxa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G8003307943","display_name":null,"funder_award_id":"81473037","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2990931063.pdf","grobid_xml":"https://content.openalex.org/works/W2990931063.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2889586005","https://openalex.org/W3040856941","https://openalex.org/W3029344012","https://openalex.org/W3192476850","https://openalex.org/W3175451049","https://openalex.org/W3173161109","https://openalex.org/W3088140463","https://openalex.org/W4392246410","https://openalex.org/W4400414008","https://openalex.org/W4320002136"],"abstract_inverted_index":{"Background:":[0],"Donafenib":[1,125],"is":[2],"a":[3,12,157,185,209],"novel":[4],"compound":[5],"similar":[6],"to":[7,20,41,143,168],"sorafenib":[8,216],"that":[9],"functions":[10],"as":[11],"multikinase":[13],"inhibitor.":[14],"This":[15],"phase":[16,181],"1b":[17,182],"trial":[18,183],"aimed":[19],"assess":[21],"the":[22,53,75,91,119,134,144,165,218],"safety,":[23],"pharmacokinetics":[24],"and":[25,62,67,87,94,112,156,164,189,204],"efficacy":[26,192,205],"of":[27,72,77,193,212],"donafenib":[28,73,84,194,213],"in":[29,52,90,129,150,153,161,217],"treating":[30,196],"Chinese":[31],"patients":[32,49,155],"with":[33,215],"advanced":[34,46,197],"hepatocellular":[35,47,198],"carcinoma.":[36,199],"Methods:":[37],"From":[38],"July":[39],"2014":[40],"April":[42],"2015,":[43],"27":[44],"eligible":[45],"carcinoma":[48],"were":[50,56,98,118,206],"enrolled":[51],"trial.":[54],"They":[55],"randomly":[57],"divided":[58],"into":[59],"200":[60],"mg":[61,64],"300":[63],"bid":[65],"groups":[66],"received":[68],"these":[69],"oral":[70],"doses":[71],"until":[74],"appearance":[76],"intolerance":[78],"or":[79,101,201],"disease":[80,159],"progression.":[81],"Results:":[82],"Overall,":[83],"was":[85,170],"safe":[86],"well":[88],"tolerated":[89],"two":[92,154],"groups,":[93],"most":[95,120],"adverse":[96,123],"events":[97],"grade":[99],"1":[100],"2.":[102],"Elevated":[103],"transaminase":[104],"(n=19,":[105,109],"70.4":[106,110],"%),":[107,111],"hypocalcemia":[108],"skin":[113],"toxicity":[114],"(n=17,":[115],"63.0":[116],"%)":[117],"frequently":[121],"encountered":[122],"events.":[124],"exhibited":[126],"high":[127],"variability":[128],"pharmacokinetic":[130],"parameters.":[131],"Areas":[132],"under":[133],"plasma":[135],"concentration\u2013time":[136],"curve":[137],"from":[138,179],"0\u201312":[139],"h":[140],"increased":[141],"disproportionally":[142],"dose":[145],"escalation.":[146],"The":[147,177],"treatment":[148],"resulted":[149],"partial":[151],"response":[152],"stable":[158],"status":[160],"17":[162],"patients,":[163],"median":[166],"time":[167],"progression":[169],"120":[171],"days":[172],"for":[173,195,208],"both":[174],"groups.":[175],"Conclusion:":[176],"results":[178],"this":[180],"indicate":[184],"favorable":[186],"safety":[187,203],"profile":[188],"notable":[190],"anticancer":[191],"Comparable":[200],"better":[202],"observed":[207],"lower":[210],"dosage":[211],"compared":[214],"literature.":[219]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-12-05T00:00:00"}